Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CTRV

ContraVir Pharmaceuticals

$0.51

-0.003 (-0.59%)

06:17
11/06/17
11/06
06:17
11/06/17
06:17
Hot Stocks
ContraVir receives approval to sell part of unused NOL's and R&D tax credits »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.65

-0.0752 (-10.37%)

06:13
10/24/17
10/24
06:13
10/24/17
06:13
Hot Stocks
ContraVir Pharmaceuticals to use preclinical services from NIAID »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$3.87

-0.13 (-3.25%)

08:11
10/23/17
10/23
08:11
10/23/17
08:11
Hot Stocks
Arrowhead presents preclinical data on development of ARO-AAT »

Arrowhead Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CTRV

ContraVir Pharmaceuticals

$0.71

-0.0176 (-2.44%)

06:04
10/19/17
10/19
06:04
10/19/17
06:04
Hot Stocks
ContraVir Pharmaceuticals doses first patient in Phase 1 renal impairment study »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

Over a month ago
CTRV

ContraVir Pharmaceuticals

$0.72

0.04 (5.88%)

06:03
10/17/17
10/17
06:03
10/17/17
06:03
Hot Stocks
ContraVir Pharmaceuticals collaborates with Li Ka Shing Institute of Virology »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

BLUE

bluebird bio

$131.50

3.75 (2.94%)

, CRSP

Crispr Therapeutics

$19.70

0.4 (2.07%)

04:55
10/10/17
10/10
04:55
10/10/17
04:55
Conference/Events
Chardan to hold a conference »

2017 Inaugural Gene…

BLUE

bluebird bio

$131.50

3.75 (2.94%)

CRSP

Crispr Therapeutics

$19.70

0.4 (2.07%)

ARWR

Arrowhead

$4.36

0.11 (2.59%)

AGTC

Applied Genetic

$4.05

0.05 (1.25%)

VBLT

VBL Therapeutics

$5.95

0.15 (2.59%)

MGEN

Miragen Therapeutics

$9.34

-0.1 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 06

    Nov

BLUE

bluebird bio

$127.75

1.75 (1.39%)

, CRSP

Crispr Therapeutics

$19.30

0.11 (0.57%)

15:51
10/09/17
10/09
15:51
10/09/17
15:51
Conference/Events
Chardan to hold a conference »

2017 Inaugural Gene…

BLUE

bluebird bio

$127.75

1.75 (1.39%)

CRSP

Crispr Therapeutics

$19.30

0.11 (0.57%)

ARWR

Arrowhead

$4.25

-0.13 (-2.97%)

AGTC

Applied Genetic

VBLT

VBL Therapeutics

$5.80

-0.3 (-4.92%)

MGEN

Miragen Therapeutics

$9.44

0.2 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 06

    Nov

ARWR

Arrowhead

$3.66

-0.08 (-2.14%)

14:06
09/27/17
09/27
14:06
09/27/17
14:06
Hot Stocks
Arrowhead results could guide new clinical approaches for HBV »

Arrowhead Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$3.30

0.51 (18.28%)

06:42
09/18/17
09/18
06:42
09/18/17
06:42
Upgrade
Arrowhead rating change at William Blair »

William Blair upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ARWR

Arrowhead

$3.30

0.51 (18.28%)

06:19
09/18/17
09/18
06:19
09/18/17
06:19
Upgrade
Arrowhead rating change at William Blair »

Arrowhead upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.